Select your country

19.12.2017
STADA: domination and profit and loss transfer agreement pursuant to sections 291 et seqq. AktG concluded between STADA Arzneimittel AG and Nidda Healthcare GmbH

STADA: domination and profit and loss transfer agreement pursuant to sections 291 et seqq. AktG concluded between STADA Arzneimittel AG and Nidda Healthcare GmbH

STADA: domination and profit and loss transfer agreement pursuant to sections 291 et seqq. AktG concluded between STADA Arzneimittel AG and …

Read more

27.09.2017
Supervisory Board of STADA Arzneimittel AG elects Dr. Günter von Au as new Chairman

Supervisory Board of STADA Arzneimittel AG elects Dr. Günter von Au as new Chairman

Supervisory Board of STADA Arzneimittel AG elects Dr. Günter von Au as new Chairman

Read more

25.08.2017
Changes on the Supervisory Board of STADA Arzneimittel AG due to the takeover by Bain Capital and Cinven

Changes on the Supervisory Board of STADA Arzneimittel AG due to the takeover by Bain Capital and Cinven

Changes on the Supervisory Board of STADA Arzneimittel AG due to the takeover by Bain Capital and Cinven

Read more

10.07.2017
Bain Capital and Cinven applied for an exemption from one-year exclusion period for the submission of a renewed voluntary public takeover offer with STADA’s consent

Bain Capital and Cinven applied for an exemption from one-year exclusion period for the submission of a renewed voluntary public takeover offer with STADA’s consent

Bain Capital and Cinven applied for an exemption from one-year exclusion period for the submission of a renewed voluntary public takeover of…

Read more

04.07.2017
Changes in the Executive Board of STADA Arzneimittel AG

Changes in the Executive Board of STADA Arzneimittel AG

Changes in the Executive Board of STADA Arzneimittel AG

Read more

04.07.2017
STADA Arzneimittel AG confirms that Bain Capital and Cinven are considering to apply for an exemption from one-year exclusion period for the submission of a renewed voluntary public takeover offer

STADA Arzneimittel AG confirms that Bain Capital and Cinven are considering to apply for an exemption from one-year exclusion period for the submission of a renewed voluntary public takeover offer

STADA Arzneimittel AG confirms that Bain Capital and Cinven are considering to apply for an exemption from one-year exclusion period for the…

Read more

26.06.2017
STADA Arzneimittel AG: Voluntary public takeover offer by Bain Capital and Cinven not successful

STADA Arzneimittel AG: Voluntary public takeover offer by Bain Capital and Cinven not successful

STADA Arzneimittel AG: Voluntary public takeover offer by Bain Capital and Cinven not successful

Read more

07.06.2017
STADA: Bain Capital and Cinven lower the minimum acceptance threshold for the takeover offer to STADA’s shareholders from 75 percent to 67.5 percent – acceptance period extended until June 22, 2017

STADA: Bain Capital and Cinven lower the minimum acceptance threshold for the takeover offer to STADA’s shareholders from 75 percent to 67.5 percent – acceptance period extended until June 22, 2017

STADA: Bain Capital and Cinven lower the minimum acceptance threshold for the takeover offer to STADA’s shareholders from 75 percent to 67.5…

Read more

10.04.2017
STADA supports the voluntary public tender offer by Bain Capital and Cinven worth Euro 66.00 per share

STADA supports the voluntary public tender offer by Bain Capital and Cinven worth Euro 66.00 per share

STADA supports the voluntary public tender offer by Bain Capital and Cinven worth Euro 66.00 per share

Read more

17.03.2017
STADA raises medium-term growth targets

STADA raises medium-term growth targets

STADA raises medium-term growth targets

Read more

23.02.2017
STADA Arzneimittel AG informs about receipt of binding, conditional take-over offer

STADA Arzneimittel AG informs about receipt of binding, conditional take-over offer

Read more

16.02.2017
STADA Arzneimittel AG confirms receipt of another non-binding expression of interest in takeover bid

STADA Arzneimittel AG confirms receipt of another non-binding expression of interest in takeover bid

STADA Arzneimittel AG confirms receipt of another non-binding expression of interest in takeover bid

Read more

13.02.2017
STADA Arzneimittel AG starts talks with potential bidders

STADA Arzneimittel AG starts talks with potential bidders

STADA Arzneimittel AG starts talks with potential bidders

Read more

12.02.2017
STADA Arzneimittel AG confirms receipt of non-binding expressions of interest in takeover bid

STADA Arzneimittel AG confirms receipt of non-binding expressions of interest in takeover bid

STADA Arzneimittel AG confirms receipt of non-binding expressions of interest in takeover bid

Read more